Jerusalem
Israel
47
2024-05-09
The entities that hold a legal rights for patent applications filed by inventor Har-Noy Michael:
Michael Har-Noy from Jerusalem, IL has applied for patents for these inventions. The list has both pending applications and granted patents:
Induction of IL-12 using immunotherapy
#2 | 2024-02-15Th1 vaccination priming for active immunotherapy
#3 | 2023-10-12Artificial lymph node bioreactor
#4 | 2023-07-20Methods for handling biological drugs containing living cells
#5 | 2023-07-13Methods for handling biological drugs containing living cells
#6 | 2022-09-01Methods and compositions for liquidation of tumors
#7 | 2021-09-02Induction of IL-12 using immunotherapy
#8 | 2020-11-26Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome
#9 | 2020-10-29Th1 vaccination priming for active immunotherapy
#10 | 2020-08-20Vaccine compositions and methods
#11 | 2019-11-21Methods for handling biological drugs containing living cells
#12 | 2019-09-26Automated device for biologic drug distribution
#13 | 2019-04-11Vaccine compositions and methods
#14 | 2018-07-19Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome
#15 | 2017-12-21Method for allogeneic cell therapy
#16 | 2017-10-12Kit for increasing Th1 cells
#17 | 2017-10-05Th1 vaccination priming for active immunotherapy
#18 | 2016-12-15Methods and compositions for inhibition of Treg cells
#19 | 2016-08-25Ablative Immunotherapy
#20 | 2016-07-21Compositions for Liquidation of Tumors
#21 | 2016-07-14Automated device for biologic drug distribution
#22 | 2016-06-09Method for allogeneic cell therapy
#23 | 2016-05-26Method of vaccinating using allogeneic cells
#24 | 2016-05-19Vaccine comprising allogeneic T-cells
#25 | 2016-03-31Allogeneic T-cell compositions for induction of IL-12
#26 | 2015-07-09Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome
#27 | 2015-01-22Device for enhancing immunostimulatory capabilities of T-cells
#28 | 2015-01-22Allogeneic cellular immunotherapy for opportunistic infection
#29 | 2014-10-02Method to formulate T-cells
#30 | 2014-07-10Method for stimulating a host immune system
#31 | 2014-06-26Methods and compositions for liquidation of tumors
#32 | 2014-06-05Method for allogeneic cell therapy
#33 | 2013-04-25Methods for handling biological drugs containing living cells
#34 | 2013-04-25Induction of IL-12 using immunotherapy
#35 | 2013-03-14Automated device for a biologic drug distribution
#36 | 2012-05-24Vaccine compositions and methods
#37 | 2011-11-17Methods to cause differentiation of T-cells for use in cell therapy
#38 | 2011-09-22Ablative immunotherapy
#39 | 2011-08-25Method for stimulating a therapeutic immune effect in a patient
#40 | 2011-08-25Method for stimulating a host immune system
#41 | 2011-07-21Device for enhancing immunostimulatory capabilities of T-cells
#42 | 2011-02-17T-cell compositions that elicit type I cytokine response
#43 | 2011-02-10Composition of activated CD4 cells
#44 | 2011-02-03Method to formulate T-cells
#45 | 2010-04-08Th1 vaccination priming for active immunotherapy
#46 | 2007-04-19Biodegradable T-cell Activation device
#47 | 2006-06-01Allogeneic cellular immunotherapy for opportunistic infection
142475 ⎘